A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
Status:
Recruiting
Trial end date:
2028-10-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about the safety and side effects of combining
entinostat, an investigational drug, with capecitabine, a drug commonly used in breast cancer
(BC), in both participants with metastatic breast cancer (MBC) and then participants with
high-risk breast cancer after neo-adjuvant therapy.